Description:Mouse monoclonal antibody to human C-C Chemokine Receptor 1 (CCR1)
Purification: Protein G affinity purified
Product Type:Primary antibody
Target Protein:C-C Chemokine Receptor 1 (CCR1)
Immunogen:A 15 amino-acid peptide corresponding to the amino acid sequence 305-319 on human CCR1 was conjugated with KLH for immunization.
Fusion Myeloma: Sp2/0-Ag14
Specificity:This antibody is reactive to the above peptide conjugated KLH. The antibody does not cross react with KLH, BSA and HSA.
Species Reactivity: Human
Host / Isotype: Mouse, IgG1 Kappa
Formulation: Lyophilized in 0.01M PBS, pH 7.0.
Reconstitution: Double distilled water is recommended to adjust the final concentration to 1.00 mg/mL.
Storage: Store at -20oC
Research Area:Chemokine Receptor
Background:
CCR1, also called CD191, is the first CC chemokine receptor identified atDNAlevel. Like other CC chemokine receptors,CCR1 is a G-protein coupled 7 transmembrane protein. Genes forCCR1 and several other chemokine forms a cluster on chromosome 3p.
A number of CC chemokines, such as MIP-1β, Rentes, MIP1-α, MIP1-delta, RANTES, and MIP3, MIP1-γ, HCC1 and HCC4 have been found to be the ligands of CCR1. CCR1 expression has been reported to be implicated in rheumatoid arthritis, chronic lymphocytic leukemia and hairy cell leukemia.
Applications:
ELISA:The antibody reacts with the CCR1 peptide KLH conjugate (Immunogen) in indirect ELISA assay.
Other applications have not been evaluated.
References: If research is published using this product, please inform Anogen in order to cite the reference on this datasheet. Anogen will provide one unit of product in the same category as gratitude.
Product Specificity | mAb anti-Human CCR1, 293 |
---|---|
Application | EIA |
Size | 0.1 mg |
Anogen-Yes Biotech Laboratories Ltd.是一家位于加拿大密西沙加的生物技术公司。成立于1989年,我们30年来一直是高质量抗体基产品的骄傲供应商。我们提供300多种单克隆和多克隆抗体,以及60多种类型的ELISA试剂盒,用于研究,诊断和治疗应用。
作为一家专注于研究的公司,我们还开发了许多专有的诊断和治疗产品。我们的产品Abcream是一种有效的抗牛皮癣局部抗IL-8(CXCL8)单克隆抗体,已于2001年获得中国国家食品药品监督管理局(SFDA)的批准,并获得多项国际专利。我们的用于诊断目的的新生儿TSH ELISA试剂盒也已获得加拿大卫生部的许可。我们还启动了针对炎症,阿尔茨海默氏病和癌症的研究和开发产品。